Hematopoietic Cell Kinase (HCK) Is Essential for NLRP3 Inflammasome Activation and Lipopolysaccharide-Induced Inflammatory Response In Vivo
Activation of the NLRP3 inflammasome results in caspase 1 cleavage, which subsequently leads to IL-1β and IL-18 secretion, as well as pyroptosis, and aberrant activation of the inflammasome is involved in several diseases such as type 2 diabetes, atherosclerosis, multiple sclerosis, Parkinson’s dise...
Main Authors: | Xiangxi Kong, Yajin Liao, Lujun Zhou, Ying Zhang, Jinbo Cheng, Zengqiang Yuan, Shukun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.581011/full |
Similar Items
-
Remdesivir Alleviates Acute Kidney Injury by Inhibiting the Activation of NLRP3 Inflammasome
by: Liang Yin, et al.
Published: (2021-05-01) -
Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease Models
by: Biswadeep Das, et al.
Published: (2021-08-01) -
Chronic mild stress-induced anhedonia in rats is coupled with the upregulation of inflammasome sensors: a possible involvement of NLRP1
by: Ceren Sahin Ozkartal, et al.
Published: (2018-07-01) -
The Inflammasome in Host Defense
by: Gang Chen, et al.
Published: (2009-12-01) -
The Role of Microglia and the Nlrp3 Inflammasome in Alzheimer's Disease
by: Kendra L. Hanslik, et al.
Published: (2020-09-01)